Real-World Cost-Effectiveness of Anti-VEGF Monotherapy vs Combination Therapy for Patients With Polypoidal Choroidal Vasculopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Eye (London, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world cost-effectiveness of anti-VEGF monotherapy and combination therapy for the treatment of polypoidal choroidal vasculopathy
Eye (Lond) 2022 Dec 01;36(12)2265-2270, J Chay, BJ Fenner, EA Finkelstein, KYC Teo, CMG CheungFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.